CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,223
edits
Arthritis Advisory Committee: Difference between revisions
no edit summary
m (Text replacement - "{{Organization" to "Catergory:Orgs {{Organization") Tag: Reverted |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Organization | |||
{{ | |OrganizationName=Arthritis Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission= | |Mission=Advise Food and Drug Administration (FDA) on arthritis, rheumatism drugs, ensuring safety, efficacy via data review | ||
|ParentOrganization=Food and Drug Administration | |||
|TopOrganization=Department of Health and Human Services | |||
|OrganizationExecutive=Designated Federal Officer | |OrganizationExecutive=Designated Federal Officer | ||
|Services=Review of drug applications; safety and efficacy assessments; policy consultation | |Services=Review of drug applications; safety and efficacy assessments; policy consultation | ||
|HeadquartersLocation=38.99583, -77.02639 | |||
|HeadquartersLocation=38. | |||
|HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | |HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | ||
|Website=https://www.fda.gov/advisory-committees/arthritis-advisory-committee | |||
}} | }} | ||
'''Arthritis Advisory Committee (AAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters concerning the treatment of arthritis, rheumatism, and related conditions. Located in Silver Spring, Maryland, the committee evaluates data on drug safety, effectiveness, and labeling related to these diseases. | '''Arthritis Advisory Committee (AAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters concerning the treatment of arthritis, rheumatism, and related conditions. Located in Silver Spring, Maryland, the committee evaluates data on drug safety, effectiveness, and labeling related to these diseases. | ||
{{ | {{Official URL (simple)|url=https://www.fda.gov/advisory-committees/arthritis-advisory-committee}} | ||
==Mission== | ==Mission== | ||
The mission of the AAC is to review and evaluate data concerning drug products for arthritis and rheumatism, providing recommendations to the FDA on approval, labeling, and post-marketing surveillance. It aims to facilitate the development of safe and effective treatments for these chronic conditions.< | The mission of the AAC is to review and evaluate data concerning drug products for arthritis and rheumatism, providing recommendations to the FDA on approval, labeling, and post-marketing surveillance. It aims to facilitate the development of safe and effective treatments for these chronic conditions.<ref>Food and Drug Administration (2025). [https://www.fda.gov/advisory-committees/arthritis-advisory-committee "Arthritis Advisory Committee"]. FDA.</ref> | ||
==Parent organization== | ==Parent organization== | ||
| Line 74: | Line 69: | ||
==Services provided== | ==Services provided== | ||
The AAC provides scientific and technical advice on drug products related to arthritis and related conditions. This includes reviewing clinical trials, safety data, and efficacy studies, and discussing the implications for public health.< | The AAC provides scientific and technical advice on drug products related to arthritis and related conditions. This includes reviewing clinical trials, safety data, and efficacy studies, and discussing the implications for public health.<ref>Food and Drug Administration (2025). [https://www.fda.gov/advisory-committees/committees-and-meeting-materials/human-drug-advisory-committees "Human Drug Advisory Committees"]. FDA.</ref> | ||
==Headquarters address== | ==Headquarters address== | ||
| Line 92: | Line 87: | ||
==References== | ==References== | ||
< | <references /> | ||